Announcements
4 February 2024
Acknowledgment of the Reviewers of Nutraceuticals in 2023
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Nutraceuticals. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.
In 2023, Nutraceuticals received 164 review reports, from 150 reviewers. This past year, we worked with reviewers from 42 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Nutraceuticals family throughout 2023, and we look forward to their continued support in 2024.
The following are the reviewers who have consented to show their names:
Abdullah Hussain | Jiraporn Leanpolchareanchai |
Agnes Farkas | Jose E. Aguilar-Toala |
Agnieszka Rudzka | Karen Ildico Hirsch-Ernst |
Agnieszka Zelek-Molik | Marek Wesolowski |
Ahmed Mediani | Maria Lopes |
Alejandro Gonzalez-Candia | Mohammed Sikander |
Alessia Mariano | Mohind Mohan |
Arulselvan Palanisamy | Muni Swamy Ganjayi |
Atheer Zgair | Natalia Piekuś-Słomka |
Avinash Kundadka Kudva | Nazir Ahmad |
Ayman Mahmoud | Noura Dosoky |
Bilal Ghalloo | Nurpudji Astuti Taslim |
Concepción Obon | Pankaj Singh |
Constantinos Giaginis | Philip Chilibeck |
Damiano Spagnuolo | Pinaki Bhattacharjee |
Dan Razvan Popoviciu | Qi Xiang |
Daryoush Babazadeh | Ravi Vumma |
Dasha Mihaylova | Roberto Cannataro |
Dedi Noviendri | Sandro Jose Ribeiro Bonatto |
Deepika Singh | Shabbir Hussain |
Elisa Belluzzi | Sharangouda Patil |
Elzbieta Wierzbicka | Silvia P. Tsanova-Savova |
Espérance Debs | Siyamak Safapour |
Fatemeh Ghiasi | Snigdha Guha |
Gizem Emre | Sonia Singh |
Gjylije Hoti | Syed Amir Ashraf |
Guillermo Cásedas | Tamás Hofmann |
Hala Zaatout | Tobias Fischer |
Haniza Hassan | Vijayaraj Radha |
Hany H. Arab | Vira Lubenets |
Hsinjung Ho | Xiuli Li |
Hunter Waldman | Yesi Desmiaty |
Insha Sultan | Yingqian Chen |
Ioana-Mirela Vasincu | Yuefan Song |
Jinle Xiang | Zhibin Liu |